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Similar to other positive-strand RNA viruses, rhi-
novirus, the causative agent of the common cold,
replicates on a web of cytoplasmic membranes,
orchestrated by host proteins and lipids. The host
pathways that facilitate the formation and function
of the replication membranes and complexes are
poorly understood. We show that rhinovirus replica-
tion depends on host factors driving phosphatidylino-
sitol 4-phosphate (PI4P)-cholesterol counter-currents
at viral replication membranes. Depending on the
virus type, replication required phosphatidylinositol
4-kinase class 3beta (PI4K3b), cholesteryl-esterase
hormone-sensitive lipase (HSL) or oxysterol-binding
protein (OSBP)-like 1, 2, 5, 9, or 11 associated with
lipid droplets, endosomes, or Golgi. Replication
invariably requiredOSBP1,which shuttles cholesterol
and PI4P betweenER andGolgi atmembrane contact
sites. Infection also required ER-associated PI4P
phosphatase Sac1 and phosphatidylinositol (PI)
transfer protein beta (PITPb) shunting PI between
ER-Golgi. These data support a PI4P-cholesterol
counter-flux model for rhinovirus replication.
INTRODUCTION
Human rhinoviruses (HRVs) are the causative agents of common
colds and have a critical role in exacerbations of asthma, chronic
obstructive pulmonary disease and cystic fibrosis (Gern, 2010).
They set off severe economic burdens, in part, because there
are no approved treatments against rhinovirus infections.
HRVs are positive-strand RNA viruses from the Enterovirus
genus of the Picornaviridae family that comprises poliovirus,
coxsackievirus (CV), enterovirus, or echovirus. Similar to togavi-
ruses, flaviviruses, or picornaviruses, they build up membrane-
associated replication complexes in the cytoplasm, composedCell Host &of lipids, viral and cellular proteins, and replicating RNA (Belov
and van Kuppeveld, 2012). In case of hepaciviruses and picorna-
viruses, the replication complexes form a tubulo-vesicular
network of endomembranes with positive curvature.
There are more than 150 HRV types in three species: HRV-A
(74 types), HRV-B (25), and HRV-C (55) (Jacobs et al., 2013).
HRV-A and HRV-B types are classified into major and minor
groups. They use intercellular adhesion molecule 1 or low-den-
sity lipoprotein (LDL) family receptors for entry, respectively.
The recently discovered HRV-C types use an unknown receptor
and are difficult to grow in standard tissue culture. Rhinovirus is
composed of an icosahedral capsid enclosing a positive-sense
single-stranded RNA genome of about 7,200 nt. It enters cells
by receptor-mediated endocytosis and uncoats upon receiving
cues from receptor binding and low pH in endosomes (Suomalai-
nen and Greber, 2013). At 30–60min after endocytic uptake, viral
RNA is uncoated and translated into a polyprotein, which is pro-
cessed by viral proteases into capsid proteins, membrane-asso-
ciated proteins, and replication proteins, including viral RNA
polymerase 3D and proteases 2A and 3C/D. This results in
drastic changes in the endomembrane system, in part due to a
block in secretion (Sharp and Estes, 2010).
How viral proteins interact with cellular factors and lipids to
build up replication membranes is important for both funda-
mental research and drug development strategies (Heaton and
Randall, 2011). For example, phosphatidylinositol (PI) and its
phosphorylated derivatives produced by PI kinases (PIK) have
key functions in membrane trafficking and signaling. There are
two classes of PI 4-kinases (class 2 and 3 PI4K). Class 3 PI4K
has been implicated in replication of hepatitis C virus and picor-
naviruses (Hsu et al., 2010; Reiss et al., 2011; Spickler et al.,
2013; van der Schaar et al., 2013). PI4K2a effectively functions
on endosomes; PI4K2b is involved in the transmission of stress
signals, and producing PI4,5P2 at the plasma membrane and
other membranes; and PI4K3a has been implicated in the forma-
tion of ER exit sites for cargo export from ER to Golgi (Balla,
2013). PI4K3b regulates membrane traffic within the Golgi and
Golgi-to-plasma-membrane transport (Godi et al., 1999). PI4Ks
produce PI4P from PI. PI4P effectors at the trans-Golgi-network
(TGN) include coat adaptors for vesicular trafficking (such as theMicrobe 16, 677–690, November 12, 2014 ª2014 Elsevier Inc. 677
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also soluble lipid transfer proteins, such as oxysterol binding
protein 1 (OSBP1) (also known as OSBP), ceramide-binding pro-
tein, and four-phosphate adaptor protein 1 and 2.
In this study, we employed targeted RNAi in combination with
lipid mass spectrometry and chemical interference to identify
host factors controlling processes in lipid metabolism for rhi-
novirus infection. Our data support a PI4P-cholesterol counter-
current model at ER-Golgi contact sites (Mesmin et al., 2013).
We extend this model by showing that HRV-A1A and -A16 infec-
tions require PI-transfer protein beta (PITPb). PITPb transfers
PI and phosphatidylcholine (PC) between membranes in vitro,
localizes to the Golgi, and is required for retrograde transport
(Carvou et al., 2010). We also demonstrate that HRV-A16 is
dependent on the cholesteryl-esterase hormone-sensitive lipase
(HSL), whereas HRV-A1A is more dependent on endosome
and Golgi-associated OSBP-like (OSBPL) proteins, such as
OSBPL1, L5, L9, and L11, and the lipid droplet (LD)-associated
OSBPL2. OSBP1 and OSBPL proteins form a large, evolution-
arily conserved family of lipid-binding proteins that mediate ste-
rol signaling and transport between membrane compartments
and hence contribute to membrane dynamics and lipid flow.
Our data provide a paradigm for ER-Golgi membrane flux in
the absence of a functional secretory pathway in rhinovirus in-
fected cells.
RESULTS
The Lipid Kinase PI4K3b Is Required for HRVReplication
HRV serotypes from species A and B require PI4Ks for infection,
as suggested by studies with chemical inhibitors (Spickler et al.,
2013; van der Schaar et al., 2013). To determine which PI4Ks
were required for HRV infection and replication, we used a
pool of small interfering RNAs (siRNA) directed against the
known PI4Ks. We addressed PI4K2a (PI4K class 2 alpha),
PI4K2b, PI4K3a, and PI4K3b and tested effects on replication
of five HRVs encompassing HRV-A species (HRV-A1A, HRV-
A2, and HRV-A16) and B species (HRV-B14 and HRV-B37).
HRV-A16, HRV-B14, and HRV-B37 are ICAM-tropic major rhino-
viruses, whereas HRV-A1A and HRV-A2 are LDLR-tropic minor
rhinoviruses. In addition, we used the enterovirus Coxsackievi-
rus B3 (CVB3), which requires PI4K3b for replication (Hsu
et al., 2010). The knock-down of PI4K3b inhibited the infection
with all tested HRV-types and also CVB3 in the range of 31%
to 80%, as scored by immunofluorescence high-throughput
assay using a double-stranded RNA (dsRNA) antibody (Fig-
ure 1A; Figure S1A available online) (Jurgeit et al., 2012; Jurgeit
et al., 2010). This was confirmed by western blotting of cell
extracts with an antibody against PI4K3b and cytotoxicity as-
sessments by cell number measurements (Figures 1A and 1B).
The knock-down of PI4K2a inhibited infection of all HRV-types
tested, particularly strongly the minor HRV-A1A and -A2, but
not CVB3, possibly highlighting a common endocytic or replica-
tion requirement for HRVs. PI4K3a knock-down strongly in-
hibited infection with minor HRV-A1A and -A2 and also reduced
the cell numbers, although this was independent of infection
inhibition, suggesting that minor HRV infections require a
functional secretory pathway. Although PI4K3a knock-down
inhibited infection with minor HRV-A1A and -A2, inhibitors of678 Cell Host & Microbe 16, 677–690, November 12, 2014 ª2014 ElsPI4K3a activity, such as AL-9, did not affect HRV replication
(data not shown; Bianco et al., 2012). PI4K2b knock-down in-
hibited HRV-A2 but did not inhibit other rhinoviruses or CVB3
(Figures S1A and S1B).
Prior genome-wide RNAi screens suggested that PI4K3b was
involved in HRV-A1A and -A16 infection (U.F.G., unpublished re-
sults). To further explore a role of PI4K3b inHRV infection,weem-
ployed the synthetic PI4K3b inhibitor PIK93. PIK93 inhibits
PI4K3b activity with in vitro half inhibitory concentration (IC50)
of 19 nM and PI4K3a with IC50 of 1 mM (Knight et al., 2006). In
both HeLa and primary human airway epithelial cells of nasal
biopsies (hAECN), PIK93 blocked infection with all HRV types
tested (A1A, A2, B14, A16, and B37) and CVB3 with effective
concentrations (EC50) ranging from 170 nM to 915 nM for
HRV-A2 and HRV-A1A, respectively (Figures 1C and S1C–S1E).
Importantly, PIK93 hadminimal effects onmetabolic activity (Fig-
ure S1F). The PIK93 inhibitory profiles against HRVs corre-
spondedwellwith theantiviral efficacyofPI4K3bsiRNAsandsur-
prisingly showed little effect on HRV-A1A (Figures 1A and 1C).
Further tests using RT-PCR for viral RNA measurements, entry
bypass assays using genomic RNA transfections, and time-
controlleddrugadditions to cells showed thatPIK93blocked viral
replication rather than entry (Figures S1G–S1L). Interestingly,
HRV-A1A infection was less sensitive to PIK93 than transfection
of viral RNA, suggesting that steps in entry render HRV-A1A rela-
tively insensitive to PIK93, compared to HRV-A16. The specific
PI4K3b inhibitor GSK2998533A blocked HRV and CVB3 infec-
tions ofHeLa cellswith EC50 values of about 30–100 nM, confirm-
ing the role of PI4K3b forHRV infection (FiguresS1MandS1L). As
expected, all HRVs and CVB3 were strongly inhibited by the
fungal metabolite brefeldin A (BFA) (10 mM, Figure 1C).
Cytoplasmic PI4P Levels Are Increased near HRV
Replication Sites
We used ion chromatography with suppressed conductivity
detection to determine the levels of PI4P in HRV-A1A- and
-A16-infected HeLa cells 30 min or 7 hr postinfection (pi). To ac-
count for variability in lipid extraction, we normalized the results
to the mass of cardiolipin (CL). PIK93 slightly reduced the PI4P
levels compared to uninfected control cells, indicating that
PI4K3b contributes to maintain the levels of PI4P at steady state
(Figure 2A). At 30min pi, infected cells had reduced levels of PI4P
compared to uninfected cells. This decrease correlated with an
increase of the PI4,5P2 levels by about 20% independent of
PIK93 treatment (data not shown). This suggests that PI4P is con-
verted to PI4,5P2 during HRV entry independent of PI4K3b activ-
ity. At 7 hr pi, the PI4P level increased by about 30% in HRV-A1A-
or A16-infected cells compared to uninfected cells. This increase
in PI4P lipidswasnot due to enhanced levels of PI4K3b, as shown
by western blotting (Figure 2B). It was, however, blunted by
PIK93 but without affecting the levels of PI4K3b in HRV-A16 in-
fected cells. The data demonstrate that PI4P lipids are increased
at the time of HRV RNA replication owing to PI4K3b activity.
We next investigated the subcellular location of PI4P in digi-
tonin-permeabilized cells using an immunofluorescence-based
assay specifically detecting cytoplasmic PI4P. Compared to un-
infected cells, the cytoplasmic PI4P signals increased in HRV-
A1A- or A16-infected cells, predominantly in the vicinity of newly
synthesized VP2 around the nucleus—for example, 8 hr but notevier Inc.
Figure 1. PI4K3b and PI4K3a Support Replication of Rhinoviruses
(A) Effects of siRNAs against PI4K2a, PI4K3a, or PI4K3b (pool of four distinct siRNAs each), or with the negative control siRNA (all star, *) on HRV-A1A, -A2, -A16,
-B14, -B37, or CVB3 infection. Minor HRV are denoted by *. Values represent means ± SD, n = 2.
(B) Western blots of lysates from HeLa cell infected with HRV-A16 (MOI 50) probed with antibodies against PI4K2a, PI4K3a, PI4K3b, or glyceraldehyde-
phosphate dehydrogenase (GAPDH).
(C) Drug treatments of HeLa (white bars) or hAECN (black bars) 1 hr prior to infection, including DMSO, brefeldin A (BFA), and PIK93. EC50 values of inhibitors on
infections (8 hr for HeLa, or 18 hr for hAECN) were obtained by nonlinear regression of the data fitted to the variable-slope sigmoidal dose-response. Values
represent means ± SD, n = 2. Refers to Figure S1.
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in the proximity of replicated viral RNA by immune staining
PI4K3b and dsRNA (Figure 2E). Interestingly, a small amount of
dsRNA-positive foci dispersed from the bulk was found to be
PI4K3b negative. In uninfected cells, PI4K3b colocalized with
the peripheral cytoplasmic TGN marker p230 and the cis-Golgi
marker GM130 but not the ER marker calnexin (Figure 2F). In in-
fected cells, newly synthesized VP2 colocalized with p230,
GM130, and the ER-Golgi intermediate compartment marker
ERGIC53 in perinuclear clusters of punctate fluorescence (Fig-
ures S2A–S2C). Intriguingly, the perinuclear VP2-positive areas
appeared to be enriched in calnexin, suggesting that HRV infec-
tion reorganized cellular compartments (Figure S2D).
To test a functional involvement of the TGN, we subjected the
cells to Exo2, a small compound disrupting the TGN and earlyCell Host &endosomes but not the ER or ERGIC (see Figure S2E) (Spooner
et al., 2008). Exo2 is more specific than BFA, which disrupts the
TGN and also the cis-Golgi (Figure S2E). Exo2 blocked HRV-A1A
and -A16 replication in a dose-dependent manner with EC50
between 16.2 and 24.6 mM, if added prior to 3 hr pi, suggesting
an involvement of the TGN in HRV replication (Figure S2F).
Together, the data show that PI4P lipids are produced by
PI4K3b in the vicinity of HRV replication sites near Golgi and
ER compartments, and viral replication requires the TGN.
HRV Infected Cells Increase Cholesterol and Reduce
Cholesteryl-Esters
Cells infected with enteroviruses, including rhinoviruses, display
high levels of positively curved cytoplasmic membranes, as indi-
cated by thin section electron microscopy (EM) (see Figure 3A).Microbe 16, 677–690, November 12, 2014 ª2014 Elsevier Inc. 679
Figure 2. PI4P and PI4K3b Are Enriched on Rhinovirus Replication Sites
(A) Total lipids extraction and PI4P measurement by ion chromatography with suppressed conductivity detection from HeLa cells treated with DMSO or 1 mM
PIK93 1 hr prior to infection with HRV-A1A or HRV-A16 (MOI 50). Values were normalized to CL and represent means ± SD, n = 3.
(B) No gross reduction of PI4K3b levels detected by western blotting upon treatment of cells with PIK93 inoculated with HRV-A16 or UV-treated HRV-A16 (MOI
50) for 8 hr. Values are means ± SD, n = 3.
(C) HeLa cells infected with HRV-A1A or HRV-A16 (MOI 20) for 8 hr were stained for viral protein VP2 (green), cytoplasmic PI4P (red), and nuclei with DAPI (blue).
Scale bar: 10 mm.
(D) HeLa cells infected with HRV-A1A or HRV-A16 were stained for cytoplasmic PI4P (green) and nuclei (blue). The total intensity of perinuclear PI4P signal for
each cell was measured and normalized to the corresponding area. Values are means ± SD, nR 36.
(E and F) HeLa cells infected with HRV-A1A or HRV-A16 (8 h) were stained for dsRNA (green), PI4K3b (red), and DAPI (nuclei, blue). Noninfected cells were stained
for p230, GM130 or calnexin (green), and PI4K3b (red). Scale bar: 10 mm. Refers to Figure S2.
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pletely explored. Toward elucidating if cholesterol was involved
in HRV replication, we analyzed the levels of cholesterol by
fluorescence microscopy and mass spectrometry. Cholesterol
staining with filipin revealed a striking colocalization with VP2
in perinuclear clusters of HRV-A1A- or A16-infected cells 8 hr
pi (Figure 3B). Fluorescence quantification showed a significant
increase in the perinuclear filipin signal 14 hr pi, and a trend to in-
crease 8 pi, albeit less pronounced in HRV-A1A- than HRV-A16-
infected cells (Figure 3C). These results were confirmed by mass
spectrometry in cell populations, showing that population levels
of cholesterol increased from 140 mg/ml before infection to 190–
220 mg/ml at 7, 15, or 22 hr pi with HRV-A16, although not signif-
icantly with HRV-A1A compared to uninfected cells (Figures 3D
and S3A). Concomitantly, the levels of cholesteryl-esters were
found to be reduced from 60 or 85 mg/ml before infection to 33
or 56 mg/ml 15 or 22 hr pi in HRV-A1A or HRV-A16 infected cells,
respectively. This suggests that cholesteryl-esters contribute to
increase cholesterol pools in rhinovirus infected cells, although
they may not be sufficient to cover the entire surge in cholesterol
in HRV-A16 infected cells.
Distinct mechanisms can increase the levels of cholesterol in
the ER membrane. One is de novo biosynthesis from acetyl
CoA through the mevalonate pathway on ER membranes,
including the rate limiting enzyme 3-hydroxy-3-methylglutaryl-
coenzyme A (HMG-CoA) reductase. A second one is uptake of
extracellular cholesterol via late endosomes, or third, hydrolysis
of cholesteryl-esters in LDs or late endosomes (Ikonen, 2008). To
determine whether de novo biosynthesis was required for HRV
replication, we tested the effect of small chemical inhibitors of
cholesterol metabolism on HRV infection and replication (Fig-
ure 3E). HeLa cells were infected with HRV-A1A or -A16 at mul-
tiplicity of infection (MOI) 20; treated with compounds, and
stained by anti-VP2 antibodies 8, 10, 12 or 14 hr pi or were
analyzed for replication of viral RNA by quantitative RT-PCR.
25-HC is produced from cholesterol by cholesterol 25-hydroxy-
lase, inhibits one of the rate limiting enzymes in cholesterol
biosynthesis HMG-CoA reductase (Kandutsch and Chen,
1974), and also blocks OSBP1 (Mesmin et al., 2013; Wang
et al., 2008). 25-HC strongly inhibited HRV-A1A and HRV-A16
infection and replication, comparable to PIK93 (Figures 3F, 3G,
1E, and 1F). 25-HC also inhibited the expression of HMG-CoA
reductase mRNA in uninfected cells to levels similar as in in-
fected cells not treated with compound (Figure 3H). In addition,
25-HC and methyl-b-cyclodextrin (MbCD), which depletes cells
of cholesterol by extracting free cholesterol frommembranes, in-
hibited HRV-A1A or -A16 infections under conditions, where the
inoculum was washed off the cells 1 hr pi, compounds added
2 hr pi, and infection scored 8 or 14 hr pi (Figure S3B). These re-
sults were similar to PIK93 and highlight that cholesterol is
required for one or several postentry steps in HRV infection
and replication. In contrast, compactin or AY9944, which inhibit
cholesterol biosynthesis at early or late steps by blocking HMG-
CoA reductase, or D7-dehydrocholesterol reductase, respec-
tively, had relatively little effect, since the drug treatments led
to 10%–30% reduction in HRV-A16 and 50% reduction in
HRV-A1A infection at 8 hr pi, but no effects were visible anymore
at 10, 12, or 14 hr pi (Figures 3F–3H). NeitherMbCD, AY9944, nor
compactin showed adverse toxicity in the resazurin metabolicCell Host &assay (Figure S3C). As expected, the cholesterol biosynthesis
inhibitors compactin (10 mM) or AY9944 (10 mM) did not reduce
but rather increased the expression of HMG-CoA reductase.
Likewise, these compounds did not inhibit HRV infection of
hAECN, as measured by dsRNA immunofluorescence (data
not shown). The data suggest that cholesterol biosynthesis has
little role in HRV replication, although cholesterol crucially sup-
ports replication.
HRV Infections Cluster Lipid Droplets near Replication
Centers and Require Hormone Sensitive Lipase
To further explore the mechanism of cholesterol increase in
rhinovirus-infected cells, we investigated if LDs were involved
in infection. LDs contain neutral lipids such as cholesteryl-esters
or triacylglycerol and a monolayer of phospholipids, as well as a
key set of proteins (Walther and Farese, 2012). Compared to un-
infected cells, the size and shape of LDs stained with LD540 and
scored by fluorescence microscopy did not significantly change
in infected cells 8 hr pi (Figures 4A and 4B). At 14 hr pi, however,
fewer and bigger LDs were detected, and some of them colocal-
ized with puncta of newly synthesized VP2.
We determined if hydrolysis of cholesteryl-esters was impli-
cated in HRV infection by treating cells with an inhibitor of HSL
which catalyzes the hydrolysis of cholesteryl-esters, tri-, di-,
and monoacyl-glycerols and is associated with LDs. The pre-
treatment of cells with the HSL inhibitor CAY10499 reduced
HRV-A1A and -A16 infections in a dose-dependent manner
with EC50 of 0.35 and 5.2 mM at 8 hr pi (Figure 4C). Addition of
CAY10499 to cells after infection decreased HRV inhibition
less effectively (EC50 values between 4 and 92.9 mM) depending
on the HRV type and the time of addition (Figure 4D). This was in
accordance with the report that the inhibition of HSL cholesteryl-
esterase activity with CAY10499 required prolonged inhibitor
pretreatment (Manna et al., 2013). Importantly, CAY10499 was
not toxic up to 64 mM (Figure 4E). In addition, RNA interference
against HSL significantly inhibited replication of HRV-A16 but
not HRV-A1A (Figures 4F–4H). The data show that some rhinovi-
ruses take advantage of host lipases to produce cholesterol from
cholesteryl-esters and thereby enhance replication on Golgi-
derived membranes.
To address how HRV-A1A accesses cholesterol, we conduct-
ed an siRNA miniscreen against OSBP-like proteins (OSBPLs),
also called OSBP-related proteins (ORPs). OSBPLs are intra-
cellular sterol sensors or transporters, frequently located at
membrane contact sites (Olkkonen and Li, 2013). Strikingly,
HRV-A1A was inhibited by RNAi against OSBPL1, L2, L5, L6,
L7, L8, L9, L10, and L11, but not L3 or L4, while the other rhino-
viruses and CVB3 were less dependent on OSBPLs (Figure 4H
and S4A–S4D). OSBPL1, L2, and L5 are implicated in ER-late en-
dosomes or ER-LDs contacts, and L3 and L4 in ER-plasma
membrane contact sites (Olkkonen and Li, 2013). Notably,
OSBPL2 is associated with LDs, and its knockdown increases
cholesteryl-ester synthesis (Hynynen et al., 2009) and thereby
could inhibit HRV-A1A infection. OSBPL5, which is located on
the ER, has been implicated in cholesterol exit from late endo-
somes and lysosomes (Du et al., 2011). Interestingly, OSBPL9
and L11 were involved not just in HRV-A1A but also -A2, -B14,
and -A16, but not -B37 or -CVB3, infections and localized near
HRV-A1A or -A16 replication sites (Figure S4A). OSBPL11 pairsMicrobe 16, 677–690, November 12, 2014 ª2014 Elsevier Inc. 681
Figure 3. Cholesterol Is Enriched on HRV Replication Sites
(A) Electronmicrographs of HeLa cells infected with HRV-A16 (MOI 1), or uninfected cells, Epon embedded and stained with uranyl acetate. Positively curved viral
replication membranes are shown by arrow heads; areas with multiple membranes closely apposed are highlighted by double arrow heads, and lipid droplets
indicated by *.
(B) HeLa cells infected with HRV-A1A or HRV-A16 for 8 hr were stained for VP2 (green) and cholesterol (blue). Scale bar: 10 mm.
(C) Quantification of filipin signal representing total cholesterol for each cell normalized to its area. Values are means ± SD, nR 7.
(legend continued on next page)
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(Olkkonen and Li, 2013). Together the data suggest that late en-
dosomes can supply cholesterol for rhinovirus replication. For
HRV-A1A, an involvement of late endosomes may compensate
for LD-associated cholesteryl-ester hydrolysis.
The PI4P-Cholesterol Exchange Protein OSBP1, VAP-B,
Sac1, and PITPb Are Required for HRV Replication
Several lines of evidence pointed to an involvement of the PI4P-
cholesterol exchange protein OSBP1 in HRV infection, namely
the increase in both PI4P and cholesterol levels at stages of viral
replication, the sensitivity of HRV infection to 25-HC, and the
infection independence of cholesterol biosynthesis. The latter
supported the notion that 25-HC inhibited HRV infection by
blocking OSBP1. In accordance with this, the treatment of cells
with 25-HC induced the clustering of OSBP1 in perinuclear
Golgi-like areas (Figure S5A). This was consistent with the
finding that 25-HC not only blocks the ability of OSBP1 to extract
sterols from the ER through its lipid transport domain (ORD) but
also extraction of PI4P from the Golgi, and hence leads to accu-
mulation of OSBP1 at Golgi-ER interface (Mesmin et al., 2013;
Wang et al., 2008).
We determined the EC50 for 25-HC-mediated enterovirus
infection inhibition in HeLa and primary cells for HRV-A1A, -A2,
-B14, -A16, B37, and CVB3. For HRV-A types, 25-HC EC50
were below 1 mM, for the B-types close to 1 mM, and for CVB3
about 4 mM without metabolic toxicity (Figures 5A–5C and
S5A–S5E). In hAECN cells, the EC50 values for 25-HC were
around 1 mM for the HRV-A types and around 2 mM for the
HRV-B types (Figures 5C and S5D). 25-HC did not inhibit
CVB3 replication in hAECN cells up to 10 mM and did not affect
the metabolic activity of cells up to 10 mM during 8 or 24 hr pe-
riods of incubation (Figure 5B). Time course addition experi-
ments showed that 25-HC addition at 1 or 3 hr pi was nearly
as effective at inhibiting HRV-A, HRV-B, or CVB3 as when added
prior to infection, although the EC50 were slightly higher upon
addition pi (Figures 5D and S5F). This shows that 25-HC has mi-
nor effects on steps prior to replication.When added 5 hr pi at the
onset of replication, however, 25-HC did not inhibit infections,
indicating that it blocked initiation of the viral replication
membranes.
To further test if OSBP1 is specifically required for HRV repli-
cation, we knocked down OSBP1 by RNAi. OSBP1 knockdown
was very efficient and inhibited infection with all HRV types
tested and CVB3, although the effects on HRV-B14, -B37, and
CVB3 were not as pronounced as on HRV-A1A, -A2, and -A16
(Figures 5E and 5F). This provides strong evidence that OSBP1
broadly enhances enterovirus infection. OSBP1 is an 807 aa(D) Quantification of cholesterol and cholesteryl-esters by mass spectrometry nor
50). Values are means ± SD, n = 3.
(E) Depiction of the cholesterol biosynthesis pathway with the limiting-rate HM
(compactin and AY9944, respectively), the cholesterol-depleting agent (MbCD),
(F) Infection profiles of HeLa cells infected with HRV-A1A or HRV-A16 in presence
cells was calculated and normalized to the mock control. Values are means ± SD
(G) Viral replication measured by RT-PCR of HRV 50 UTR in HeLa cells infected w
AY9944 1 hr prior to infection. Data are normalized to the respective geometric m
(EEF).
(H) Reduction of HMG-CoA reductase expression in HRV-A1A- or HRV-A16-infect
GAPDH, TRFC, and EEF. Values are means ± SD, n = 3. Refers to Figure S3.
Cell Host &multidomain protein with an N-terminal PH domain, a FFAT
(two phenylalanines in an acidic track) motif, and a C-terminal
ORD domain (Figure 5G). It localizes at ER-Golgi contact sites
by binding simultaneously Golgi PI4P through its PH domain
and the ER vesicle-associated membrane protein (VAMP)-asso-
ciated protein A or B (VAP-A or VAP-B, respectively) via its FFAT
motif. Expression of FLAG (phenylalanine-leucine-alanine-
glycine)-tagged OSBP1 in uninfected cells showed a tight local-
ization of the protein in a perinuclear area, reminiscent of Golgi
localization (Figure 5H) (Amako et al., 2009). In HRV-A1A- or
A16-infected cells, FLAG-OSBP1 was more dispersed than in
uninfected cells and localized to areas positive for VP2, for
example, 8 hr pi. An OSBP mutant lacking the PH domain
(DPH-OSBP1) was distributed throughout the cytoplasm but
not on the Golgi. Its expression led to a clear reduction of VP2
signals, suggesting that it reduced infection by acting as a domi-
nant-negative protein interfering with the function of the endog-
enous OSBP1, possibly displacing endogenous OSBP1 from
VAP-B. Strikingly, DPH-OSBP1 did not colocalize with VP2, indi-
cating that the PH domain binding to PI4P was crucial for the
recruitment of OSBP1 to newly synthesized VP.
OSBP1 and also yeast Osh4p shuttle cholesterol against a
concentration gradient of cholesterol from the ER to the Golgi,
and this involves the ER-associated OSBP1 binding protein
VAP-A, the ER-associated PI4P phosphatase Sac1, and the
PI-transfer protein PITPb (de Saint-Jean et al., 2011; Mesmin
et al., 2013; Olkkonen and Li, 2013). The driving force for choles-
terol shuttling against its concentration gradient comes from
shuttling PI4P along its concentration gradient from Golgi to
ER, at ER-Golgi contact sites. Using RNAi, we found that the
knockdown of VAP-B, Sac1, or PITPb inhibited infection with
HRV-A1A and -A16, as measured by dsRNA high-throughput
fluorescence microscopy or western blotting with an antibody
against VP2, which also detects the viral polyprotein precursor
VP0 (Figures 5I and 5J). The data support a model where a cycle
of PI4P, cholesterol, and PI lipids between the ER and the Golgi
drives the replication of rhinovirus on Golgi membranes in close
proximity to the ER.
DISCUSSION
How different lipid species act together to build up viral replica-
tion compartments is poorly understood. We analyzed host fac-
tors controlling the flux of the phosphoinositide PI4P and the
neutral lipids cholesterol and cholesteryl-esters in rhinovirus-in-
fected cells (Figure 6A). Increased levels of PI4P were found on
Golgi membranes of infected cells by virtue of PI4K3b, and
cholesterol was increased near viral replication sites. The lipidmalized to the phospholipid (PL) in HRV-A1A- and HRV-A16-infected cells (MOI
G-CoA reductase and inhibitors of early and late cholesterol biosynthesis
and the OSBP1 ligand 25-HC depicted in red.
or absence of 25-HC, compactin, or AY9944 added 1 hr pi. The ratio of infected
, n = 2.
ith HRV-A1A or HRV-A16 (8 hr) and treated with 25-HC, PIK93, compactin, or
eans of GAPDH, transferrin receptor (TRFC), and eukaryotic elongation factor
ed cells measured by RT-PCR normalized to the respective geometricmeans of
Microbe 16, 677–690, November 12, 2014 ª2014 Elsevier Inc. 683
(legend on next page)
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membrane contact sites and is broadly required for rhinovirus
replication, as well as the ER phosphatase Sac1 hydrolyzing
PI4P, presumably to preclude PI4P competition for sterol bind-
ing on OSBP1.
We also show that rhinovirus-infected cells utilize cholesteryl-
esters from LDs or late endosomes to produce cholesterol,
which is key for replication. Our model depicted in Figure 6B ex-
tends a recently proposed one-to-one counter-current sterol to
PI4P gradient model for forward trafficking of sterols from the
ER to the Golgi (de Saint-Jean et al., 2011; Mesmin et al.,
2013). Lipid flux between adjacent membrane compartments
may be akin to treadmilling of polymer subunits in cytoskeletal
filaments. Yet, the PI4P-cholesterol flux likely involves the
coupling of additional lipids in rhinovirus replication, such as
PC through PITPb. This may enhance the complexity of lipids
building up the membranous web for the replication of posi-
tive-sense RNA viruses. These lipids likely codetermine mem-
brane curvature, dynamics, and recruitment of effector proteins,
including viral polymerase, or may simply counteract the loss of
secretory membrane flux imposed by viral proteins.
Rhinovirus Replication Is Initiated on Golgi Membranes
We show that a range of rhinoviruses require Golgi membranes
and PI4K3b to establish their replication sites in the proximity
of the TGN, the ER, and the ERGIC, in line with other enterovi-
ruses, such as poliovirus, and CVB3 (Belov and van Kuppeveld,
2012; Hsu et al., 2010; Spickler et al., 2013). HRV replication crit-
ically depended on the activity of PI4K3b. PI4K3b was not
increased during HRV replication but recruited to sites of RNA
replication where it increased the pool of PI4P lipids. Both
HRV-A1A and -A16 upregulated PI4P lipids, and this was blunted
by the PI4K3b inhibitor PIK93, which is known to block replica-
tion of HRV-A, -B, and -C types (Mello et al., 2014; Spickler
et al., 2013). The data also provide validation for an emerging
antiviral concept, namely to blunt virus-induced cellular activities
by inhibiting but not eliminating host factors, thereby gaining
antiviral efficacy with minimal collateral damage.
We also found that rhinovirus infection depended on PI4K2a,
which localizes to the TGN and endosomes and participates in
vesicular trafficking between endosomes and TGN (Wang
et al., 2003). Using population measurements in presence of
PIK93, PI4K2a activity was apparently not increased in infection,
raising the possibility that PI4K2a controls a constitutive pro-Figure 4. Lipid Droplets Are a Source of Cholesterol Source for HRV-A
(A) HeLa cells infected with HRV-A1A or HRV-A16 were stained for lipid droplets
(B) CAY10499, an inhibitor of LD-associated cholesteryl-esterase inhibits HRV-A1
of infected cells normalized to uninfected controls. EC50 values were obtained b
response. Values are means ± SD, n = 2.
(C and D) Pre- rather than post-entry addition of CAY10499 inhibits infection wi
determined as described in (B). Values are means ± SD, n = 2.
(E) CAY10499 does not affect the metabolic activity of cells up to 64 mM comp
determined by resazurin assays. Values are means ± SD, n = 4.
(F) Knockdown of HSLwith a pool of four siRNAs inhibits HRV-A16 but not HRV-A1
SD, n = 2.
(G)Western blots against HSL from lysates of HeLa cells infected with HRV-A16 (M
GAPDH.
(H) RNAi against OSBPL proteins differentially affects infection with HRV-A1A, -A2
throughput microscopy assays 8 hr pi. Minor HRV are denoted by *. Related to F
Cell Host &cess, possibly virus uptake into cells, and may not globally
induce PI4P levels to support infection. This does not exclude
a local induction of PI4K2a activity, for example, similar to the en-
try of adenovirus, which activates about 3% of the total cellular
pool of protein kinase A (Suomalainen et al., 2001). Interestingly,
PI4K3a, which controls the formation of ER exit sites (Farhan
et al., 2008), supported infection with the minor HRV-A1A and
-A2 types and could be involved in the entry or replication of
LDL-receptor tropic HRVs.
Cholesterol and Cholesteryl-Esters Are Crucial for HRV
Replication
Rhinovirus-infected cells have high levels of positively curved
cytoplasmic membranes, similar to other enteroviruses. Choles-
terol insertion into a lipid bilayer determines the equilibrium
curvature and increases bending stiffness ofmembranes (Bruck-
ner et al., 2009). One possibility for acquiring cholesterol is re-
ceptor-mediated endocytosis, as suggested for poliovirus and
CV (Ilnytska et al., 2013). HRV replication was not inhibited by
the knockdown of Rab5, Rab11, DAB2, HIP1, or Epsin15L, but
Rab18 knockdown, which affects the formation of lipid droplets,
reduced HRV infection (data not shown). We observed increased
levels of cholesterol at sites of replication, although HRV-A1A
did not increase the overall cholesterol levels in cells, unlike
HRV-A16.
A major fraction of cholesterol increase correlated with a
reduction of cholesteryl-esters for both HRV-A1A and -A16
and was at least in part due to the cholesteryl-esterase HSL.
Notably, mass balance considerations indicated that the
decrease in cholesteryl-esters unlikely accounts for the full in-
crease in cholesterol in HRV-A16-infected cells. Interestingly,
HSL is associated with LDs particularly upon activation of
lipolysis, and hydrolyzes a broad range of cholesteryl esters, tri-
glycerides, and lipoidal esters (Hashimoto et al., 2012), which
could be used to synthesize cholesterol as long as HMG-CoA
reductase is available in cells. In fact, we found that LDs coa-
lesced near the rhinovirus replication sites indicating their mobi-
lization. Interestingly, HRV-A1A infection, which occurs through
late endosomes was weakly inhibited by CAY10499 (EC50
5.2 mM versus 0.35 mM for HRV-A16) and was not sensitive to
knockdown of HSL, raising the possibility that cholesteryl-esters
from other organelles than LDs are recruited for HRV-A1A repli-
cation. Strikingly, OSBPL1 (also known as ORP1L) and OSBPL5
were required for infection with LDL-receptor-dependent16 Replication
(LD = green), VP2 (red), and nuclei (DAPI, blue). Scale bar: 10 mm.
6 and to a lesser extent HRV-A1A. Infectionwas scored by determining the ratio
y nonlinear regression of the data fitted to the variable-slope sigmoidal dose-
th HRV-A16 and to a lesser extent HRV-A1A. Infection and EC50 values were
ared to DMSO solvent and 0.01% SDS (positive control) upon treatments as
A infection compared with the negative control siRNA (all star). Values: mean ±
OI 50, 8 hr), including the VPs VP0 and VP2 (mab 16-7, Jurgeit et al., 2010) and
, -B14, -A16, -B37, and CVB3, as indicated by dsRNA infection readout in high-
igure 4.
Microbe 16, 677–690, November 12, 2014 ª2014 Elsevier Inc. 685
Figure 5. OSBP1 Broadly Supports Enterovirus Infections
(A) 25-HC blocks HRV-A1A and -A16 infections of HeLa or hAECN cells measured by dsRNA immunofluorescence.
(B) 25-HC does not affect the cell metabolic activity measured by resazurin assay. Values are means ± SD, n = 4.
(C) EC50 values for 25-HC against HRV or CVB3 infections of HeLa or hAECN cells upon pretreatment of cells. Means ± SD, n = 2.
(D) EC50 values for 25-HC added 1, 3, or 5 hr pi. Means ± SD, n = 2.
(legend continued on next page)
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Figure 6. The PI4K3b-OSBP1-Sac1-PITPb
Cycle Is Fueled by Storage Cholesterol and
Drives Rhinovirus Replication
(A) Model for host factors and inhibitor profiling
data for HRV replication (this study), including
location of PI4Ks and OSBPL proteins (Balla, 2013;
Carvou et al., 2010; Manna et al., 2013; Mesmin
et al., 2013; Olkkonen and Li, 2013).
(B) Lipid counter-current flux for rhinovirus replica-
tion. (1) Tethering or activation of PI4K3b to Golgi
membranes by one or several viral membrane
associated proteins. (2) Production of PI4P lipids
on theGolgi. (3) Nonvesicular transport of PI4P from
Golgi to ER and cholesterol from ER to Golgi
through OSBP1. (4) Hydrolysis of cholesteryl-esters
from LDs associated with ER (4a) or late endo-
somes ([4b] and [4c]), and minor contribution
from newly synthesized cholesterol (question mark,
[4d]). (5) Hydrolysis of PI4P to PI in the ER. (6)
Transport of PI from ER to Golgi through the PI
transfer protein PITP-b. (7) These events support
viral RNA replication and involve RNA-dependent
RNA polymerase 3D.
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Lipid Flux at ER-Golgi for Rhinovirus InfectionHRV-A1A and -A2, suggesting a role of late endosomal choles-
terol for minor HRVs. OSBPL1 can simultaneously bind Rab7
and VAP on late endosomes and the ER, respectively, and
thereby contribute to the formation of membrane contact sites
(Rocha et al., 2009). It may assist the recruitment of cholesterol
from late endosomes. In addition, OSBPL11 knockdown
strongly inhibited HRV but not CV replication. OSBPL11 contains
a PH domain that binds to PI4P, and can dimerize with OSBPL9,
which is located at ER and Golgi membranes. We speculate that
HRV recruits additional cholesterol via OSBPL11 independent of
OSBP1.
OSBP1 Is a Key Effector of PI4P and Cholesterol Flux
and Drives Rhinovirus Replication
OSBP1 plays a central role in enterovirus infection. It is found
at membrane contact sites, in particular between the ER and
Golgi where it binds PI4P and Arf1-GTP through a PH domain,(E) RNAi against OSBP1 (pools of four individual siRNAs) compared to the negative control siRNA (all star) inh
of HeLa cells. Values are means ± SD, n = 2.
(F) Western blots against OSBP1 from lysates of HeLa cells infected with HRV-A16 (MOI 50, 8 hr), includin
(G) Schematic depiction of OSBP1 containing a PH domain that binds PI4P and Arf1-GTP on Golgi membr
membranes, and an OSBP-related ligand-binding domain (ORD) that shuttles cholesterol and PI4P betwee
(H) Immunofluorescence analyses of FLAG-tagged OSBP1 or PH-domain lacking FLAG-OSBP1 (DPH FLAG
A1A or -A16 (8 hr). VP2 staining (green), FLAG-tagged OSBP1 (red), and nuclei (DAPI, blue). Scale bar: 10
(I) RNAi against VAP-B, Sac1, or PITP-b (pools of four individual siRNAs each) compared to the negative
infection of HeLa cells (8 hr). Values are means ± SD, n = 2.
(J) Western blots against VAP-B, Sac1, and PITPb from lysates of HeLa cells infected with HRV-A16 (MOI 50,
Refers to Figure S5.
Cell Host & Microbe 16, 677–690, Nand VAP through its FFAT domain, and
thereby functions as a nonvesicular
cholesterol transporter equilibrating free
cholesterol and PI4P between the ER
and the Golgi (Goto et al., 2012; Mesmin
et al., 2013). A PH-domain-deleted
OSBP1 mutant was not found near viral
replication sites but inhibited rhinovirusinfection, highlighting the importance of OSBP1 binding to
PI4P. In addition, OSBP1 integrates cholesterol levels with cell
growth (Raychaudhuri and Prinz, 2010). Under conditions of
abundant cholesterol, it sequesters protein phosphatases and
thereby derepresses MAP kinase signaling and cell growth,
or it functions as a sterol-dependent transducer in cytokine
signaling through signal transducer and activator of transcrip-
tion-3 (STAT3) and Janus-activated kinase-2, which phosphory-
lates OSBP1 and renders it a scaffold for binding STAT3 (Romeo
and Kazlauskas, 2008). The engagement of OSBP1 at choles-
terol-rich replication sites could thus tune the cytokine response
to rhinovirus infection.
OSBP1 is a target of natural and synthetic compounds with
therapeutic potential (Burgett et al., 2011). The oxysterol variant
25-HC binds with higher affinity to OSBP1 than cholesterol,
locks OSBP1 in a lipid exchange-inactive state, and inhibits
replication of rhinoviruses and also CVB3. This was similar to aibits rhinovirus and to a lesser extent CVB3 infection
g blots against VP0, VP2, and GAPDH.
anes, an FFAT motif that binds VAP proteins on ER
n membranes.
-OSBP) expressed in HeLa cells infected with HRV-
mm.
control siRNA (all star) inhibits HRV-A1A and -A16
8 hr), including blots against VP0, VP2, and GAPDH.
ovember 12, 2014 ª2014 Elsevier Inc. 687
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response and has innate antiviral effects (Blanc et al., 2013; Liu
et al., 2013). This likely involves an ER docking site for OSBP1,
VAP, which is targeted by interferon-inducible transmembrane
protein 3 (IFITM3), leading to endosomal cholesterol accumula-
tion and inhibition of enveloped virus entry (Amini-Bavil-Olyaee
et al., 2013). We observed inhibition of HRV-A16 but not -A1A
entry with 25-HC (Figure S5E), albeit at higher doses than block-
ing replication. Collectively, we conclude that rhinoviruses build
up PI4P-rich Golgi membranes through PI4K3b to trigger lipid
flux. We expect that other viruses than enteroviruses replicating
on cytoplasmic membranes upregulate lipid signaling branches
to generate membrane asymmetry that is critical for driving lipid
counter-flux on replication membranes and thereby enhance
viral replication.
EXPERIMENTAL PROCEDURES
Chemicals, plasmids and antibodies, cell lines, western blotting, reverse
transcription PCR, image acquisitions, and analyses are described in Supple-
mental Information. Infections were at MOI 20, unless indicated otherwise.
Figures were assembled using Adobe Photoshop and Illustrator. Graphs
represent mean values of analyzed samples (n) including the SD and p values
from t tests.
Primary Cells and Viruses
Human airway epithelial cells from nasal biopsies (hAECN) were cultured as
recommended by the supplier (Epithelix, Geneva). HRV-A1A, -A2, -B14,
-A16, -B37, and CVB3 were used as described (Jurgeit et al., 2010).
Lipid Extraction and Analyses
Phosphoinositides from HeLa cells were analyzed by ion chromatography with
suppressed conductivity detection. Lipids were extracted into chloroform,
dried, and fractionated by anion-exchange high-performance liquid chroma-
tography (HPLC), and PI4P lipids were expressed as normalized to mitochon-
drial CL. For cholesterol and cholesteryl-ester analyses, HeLa-O cells were
treated with inhibitors and infected with purified HRVs (MOI 50) in Dulbecco’s
modified Eagle’s medium supplemented with 2% fetal bovine serum and 1%
NEA at 37C. Lipids were extracted into chloroform:methanol and analyzed in
an Agilent HPLC 1100 system (Agilent) coupled with an Applied AB Sciex 3200
QTrap mass spectrometer (AB Sciex, Foster City). Cholesterol and choles-
teryl-esters were separated by an Agilent Zorbax Eclipse XDB-C18 column,
and their respective levels normalized to phospholipid levels.
Interference and High-Throughput Infection
siRNAs (20 nM)were reverse transfected toHeLa-O cells in 96-well plates using
serum-free Opti-MEM (Invitrogen) and Lipofectamine RNAiMAX (Invitrogen)
according to the manufacturer’s protocol for 72 hr and infected with HRVs or
CV at MOI 20 for 8 hr. Alternatively, cells were treated with chemical com-
pounds, infected with HRV or CV, and scored for infection by immunostaining
withmabJ2 or anti-VP2 antibodies. Imageswere acquiredwith an ImageXpress
Micro microscope (Molecular Devices) in automated mode, using a CoolSNAP
HQ 12bit gray scale camera (Roper Scientific) and 103/NA 0.5 objective
(Nikon), and analyzed with a custom-written script in Matlab (MathWorks,
Inc., Natick). Infection indexes (fraction of infected cells per total cell number)
were plotted with GraphPad Prism software (GraphPad) as relative units. Typi-
cally, infections under normal conditions yielded 30%–40% infected cells.
Immunofluorescence and Confocal Microscopy
HeLa-O cells on coverslips were treated 1 hr prior to infection with compounds
or transfected with plasmid DNA using Lipofectamine 200 (Invitrogen) 24 hr
prior to infection. Plasma membrane and cytoplasmic PI4P pools or other an-
tigens were detected in cells fixed with 4% PFA and permeabilized with 0.2%
Triton X-100, blocked for 1 hr in PBS supplemented with 1% bovine serum al-
bumin (BSA), followed by primary IgM antibodies in blocking buffer overnight688 Cell Host & Microbe 16, 677–690, November 12, 2014 ª2014 Elsat 4C followed by Alexa Fluor-488 or -594 secondary antibodies for 1 hr.
Cholesterol was stained with filipin in PBS for 30 min in cells fixed with 4%
PFA. Coverslips were mounted in mounting medium (Dako) and analyzed
with an inverted Leica TCS SP5 scanning laser confocal microscope with an
HCX PL APO 633/1.4 oil immersion objective. Images were acquired using
LAS AF software (Leica) and processed with ImageJ (National Institutes of
Health).
EM
Transmission EM of HeLa cells infected with HRV-A16 (MOI 1) for 15 hr at 33C
was carried out as described earlier (Strunze et al., 2011).
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